Three patients had endocrine neoplasia 1 (MEN1), and only two patients (5%) presented with tumor-associated symptoms, such as ectopic adenocorticotropic hormone (ACTH) and Cushing’s syndromes. Here, POMC is linked to multiple endocrine neoplasia type 1.